Orbactiv (oritavancin)

**Product type:** Human Prescription Drug

**Active ingredient:** ORITAVANCIN

**Strength:** 400 mg/1

**Dosage form:** Injection, Powder, Lyophilized, For Solution

**Route:** Intravenous

**Labeler:** Melinta Therapeutics, LLC

**Marketing category:** NDA (NDA206334)

**Pharmacologic class:** Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Lipoglycopeptide Antibacterial [EPC], Lipoglycopeptides [CS]